Axcella Health Inc (AXLA) ^Track

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Share on Twitter

Get access to advanced features

Subscribe to better monitor insider activity

Stock chart

Ticker: AXLA Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
March 18, 2022	March 16, 2022	B Purchase	Epstein David R Non-Executive Director	26,178 +19.4% 1.91 50,000 USD	26,178 +19.4%	1.91	50,000 USD
March 18, 2022	March 16, 2022	B Purchase	Flagship Ventures Fund IV General Partner LLC Major owner	1,579,843 +54.7% 1.91 3,017,500 USD	1,579,843 +54.7%	1.91	3,017,500 USD
March 18, 2022	March 16, 2022	B Purchase	Flagship Ventures Fund IV General Partner LLC Major owner	947,905 +89.7% 1.91 1,810,499 USD	947,905 +89.7%	1.91	1,810,499 USD
March 18, 2022	March 16, 2022	B Purchase	Flagship Ventures Fund IV General Partner LLC Major owner	3,791,623 +78.8% 1.91 7,242,000 USD	3,791,623 +78.8%	1.91	7,242,000 USD
March 18, 2022	March 16, 2022	B Purchase	Fehlner Paul SVP & Chief Legal Officer Officer	10,471 +101.4% 1.91 20,000 USD	10,471 +101.4%	1.91	20,000 USD
March 18, 2022	March 16, 2022	B Purchase	Crane Robert Chief Financial Officer Officer	39,267 +inf% 1.91 75,000 USD	39,267 +inf%	1.91	75,000 USD
March 18, 2022	March 16, 2022	B Purchase	Hinshaw William President & CEO Executive Director	13,089 +37.5% 1.91 25,000 USD	13,089 +37.5%	1.91	25,000 USD
March 16, 2022	March 16, 2022	B Purchase	Societe des Produits Nestle S.A. Major owner	3,141,361 +73.0% 1.91 6,000,000 USD	3,141,361 +73.0%	1.91	6,000,000 USD
May 21, 2020	May 18, 2020	B Purchase	Nestle Health Science US Holdings, Inc. Major owner	1,936,842 +81.8% 4.75 9,200,000 USD	1,936,842 +81.8%	4.75	9,200,000 USD
May 20, 2020	May 18, 2020	B Purchase	Flagship Ventures Fund IV General Partner LLC Major owner	1,900,000 +192.7% 4.75 9,025,000 USD	1,900,000 +192.7%	4.75	9,025,000 USD
May 20, 2020	May 18, 2020	B Purchase	Flagship Ventures Fund IV General Partner LLC Major owner	380,000 +56.2% 4.75 1,805,000 USD	380,000 +56.2%	4.75	1,805,000 USD
May 20, 2020	May 18, 2020	B Purchase	Flagship Ventures Fund IV General Partner LLC Major owner	1,520,000 +46.2% 4.75 7,220,000 USD	1,520,000 +46.2%	4.75	7,220,000 USD
May 20, 2020	May 18, 2020	B Purchase	Epstein David R Non-Executive Director	50,000 +73.4% 4.75 237,500 USD	50,000 +73.4%	4.75	237,500 USD
March 2, 2020	Feb. 28, 2020	B Purchase	Epstein David R Non-Executive Director	2,005 +3.0% 3.75 7,519 USD	2,005 +3.0%	3.75	7,519 USD
March 2, 2020	Feb. 27, 2020	B Purchase	Epstein David R Non-Executive Director	12,800 +24.0% 3.65 46,720 USD	12,800 +24.0%	3.65	46,720 USD
Jan. 31, 2020	Jan. 31, 2020	B Purchase	Chardonnet Laurent Chief Financial Officer	3,000 +451.1% 4.94 14,820 USD	3,000 +451.1%	4.94	14,820 USD
Jan. 28, 2020	Jan. 27, 2020	B Purchase	Chardonnet Laurent Chief Financial Officer	352 +112.5% 4.94 1,739 USD	352 +112.5%	4.94	1,739 USD
Jan. 28, 2020	Jan. 24, 2020	B Purchase	Chardonnet Laurent Chief Financial Officer	313 +inf% 4.92 1,540 USD	313 +inf%	4.92	1,540 USD
Jan. 21, 2020	Jan. 17, 2020	B Purchase	Sohn Catherine A.	1,000 +inf% 4.87 4,870 USD	1,000 +inf%	4.87	4,870 USD
Dec. 3, 2019	Nov. 27, 2019	B Purchase	Epstein David R Non-Executive Director	1,005 +1.9% 3.91 3,930 USD	1,005 +1.9%	3.91	3,930 USD
Dec. 2, 2019	Nov. 27, 2019	B Purchase	Epstein David R Non-Executive Director	1,005 +1.9% 3.91 3,930 USD	1,005 +1.9%	3.91	3,930 USD
Dec. 3, 2019	Nov. 26, 2019	B Purchase	Epstein David R Non-Executive Director	14,000 +36.6% 3.55 49,700 USD	14,000 +36.6%	3.55	49,700 USD
Dec. 2, 2019	Nov. 26, 2019	B Purchase	Epstein David R Non-Executive Director	14,000 +36.6% 3.55 49,700 USD	14,000 +36.6%	3.55	49,700 USD
Aug. 5, 2019	Aug. 2, 2019	B Purchase	Epstein David R Non-Executive Director	2,849 +8.0% 7.04 20,057 USD	2,849 +8.0%	7.04	20,057 USD
Aug. 5, 2019	Aug. 1, 2019	B Purchase	Epstein David R Non-Executive Director	4,092 +13.1% 6.98 28,562 USD	4,092 +13.1%	6.98	28,562 USD
July 18, 2019	July 17, 2019	B Purchase	Epstein David R	1,000 +3.3% 7.55 7,550 USD	1,000 +3.3%	7.55	7,550 USD
July 10, 2019	July 10, 2019	B Purchase	Epstein David R	1,322 +4.6% 8.07 10,669 USD	1,322 +4.6%	8.07	10,669 USD
July 10, 2019	July 9, 2019	B Purchase	Epstein David R	4,200 +16.9% 8.24 34,608 USD	4,200 +16.9%	8.24	34,608 USD
July 10, 2019	July 8, 2019	B Purchase	Epstein David R	274 +1.1% 9.00 2,466 USD	274 +1.1%	9.00	2,466 USD
July 3, 2019	July 3, 2019	B Purchase	Epstein David R	56 +0.3% 8.99 503 USD	56 +0.3%	8.99	503 USD
July 3, 2019	July 2, 2019	B Purchase	Epstein David R	3,500 +22.6% 8.77 30,678 USD	3,500 +22.6%	8.77	30,678 USD
July 3, 2019	July 1, 2019	B Purchase	Epstein David R	1,000 +6.9% 8.74 8,735 USD	1,000 +6.9%	8.74	8,735 USD
July 1, 2019	June 28, 2019	B Purchase	Epstein David R	5,400 +37.0% 10.04 54,216 USD	5,400 +37.0%	10.04	54,216 USD
July 1, 2019	June 27, 2019	B Purchase	Epstein David R	100 +0.7% 9.15 915 USD	100 +0.7%	9.15	915 USD
June 27, 2019	June 26, 2019	B Purchase	Epstein David R	14,500 +inf% 9.57 138,765 USD	14,500 +inf%	9.57	138,765 USD
May 15, 2019	May 13, 2019	B Purchase	Flagship Ventures Fund IV General Partner LLC Major owner	500,000 +102.9% 20.00 10,000,000 USD	500,000 +102.9%	20.00	10,000,000 USD

Get access to advanced features

Axcella Health Inc (AXLA) Track

Get access to advanced features

Stock chart

Transactions

Insider

Sort by

Axcella Health Inc (AXLA) ^Track